Effects of Azole Antifungal Drugs on the Transition from Yeast Cells to Hyphae in Susceptible and Resistant Isolates of the Pathogenic Yeast Candida albicans
- 1 April 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (4), 763-768
- https://doi.org/10.1128/aac.43.4.763
Abstract
Oral infections caused by the yeast Candida albicansare some of the most frequent and earliest opportunistic infections in human immunodeficiency virus-infected patients. The widespread use of azole antifungal drugs has led to the development of drug resistance, creating a major problem in the treatment of yeast infections in AIDS patients and other immunocompromised individuals. Several molecular mechanisms that contribute to drug resistance have been identified. InC. albicans, the ability to morphologically switch from yeast cells (blastospores) to filamentous forms (hyphae) is an important virulence factor which contributes to the dissemination ofCandida in host tissues and which promotes infection and invasion. A positive correlation between the level of antifungal drug resistance and the ability to form hyphae in the presence of azole drugs has been identified. Under hypha-inducing conditions in the presence of an azole drug, resistant clinical isolates form hyphae, while susceptible yeast isolates do not. This correlation is observed in a random sample from a population of susceptible and resistant isolates and is independent of the mechanisms of resistance.35S-methionine incorporation suggests that growth inhibition is not sufficient to explain the inhibition of hyphal formation, but it may contribute to this inhibition.Keywords
This publication has 38 references indexed in Scilit:
- Resistance of Candida albicans to Fluconazole During Treatment of Oropharyngeal Candidiasis in a Patient with AIDS: Documentation by In Vitro Susceptibility Testing and DNA Subtype AnalysisClinical Infectious Diseases, 1994
- Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variationJournal of General Microbiology, 1992
- PUTATIVE VIRULENCE FACTORS OF CANDIDA ALBICANSAnnual Review of Microbiology, 1991
- Mode of Action of Itraconazole: Morphological AspectsMycoses, 1989
- Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitroJournal of Antimicrobial Chemotherapy, 1986
- Culture Media for the Study of the Effects of Azole Derivatives on Germ Tube Formation and Hyphal Growth of C. albicans/Nährböden zur Untersuchung der Wirkungen von Azolderivaten auf die Keimschlauchbildung und das Hyphenwachstum bei C. albicansMycoses, 1986
- Effects of Imidazole- and Triazole-derivative Antifungal Compounds on the Growth and Morphological Development of Candida albicans HyphaeMicrobiology, 1985
- In-vitro resistance to imidazole antifungals in Candida albicansJournal of Antimicrobial Chemotherapy, 1984
- Effect of imidazole antifungals on the development of germ tubes by strains of Candida albicansJournal of Antimicrobial Chemotherapy, 1983
- The effect of altered ergosterol content on the transport of various amino acids in Candida albicansBiochimica et Biophysica Acta (BBA) - Biomembranes, 1979